Kilian Schober
banner
kischober.bsky.social
Kilian Schober
@kischober.bsky.social
MD Microbiology & Virology. Understanding & Engineering Human T Cell Immunity in Erlangen, Germany (www.schoberlab.de). Cycling. BVB. Cinema. Family.
Pinned
When a T cell carries both its natural TCR and an engineered CAR, do these two receptors cooperate - or compete?

Our new preprint on bioRxiv shows that TCR activation can enhance CAR-T activation but impairs CAR-mediated killing when targets are on separate cells.

www.biorxiv.org/content/10.1...
TCR activation impairs CAR-T cytotoxicity against separate target cells
Chimeric antigen receptor T cells (CAR-T) are effective therapeutics against cancer and autoimmunity, but whether the endogenous T cell receptor (TCR) is beneficial, detrimental or irrelevant for CAR ...
www.biorxiv.org
Reposted by Kilian Schober
Antigen-reactive CD4+ T cells after SARS-CoV-2 vaccination show divergent phenotypic states with or without restimulation bias https://www.biorxiv.org/content/10.1101/2025.11.19.688845v1
November 21, 2025 at 11:16 PM
🚀 New bioRxiv preprint!
We used a standardized SARS-CoV-2 mRNA vaccination model to study antigen-reactive CD4⁺ T cells in their resting and stimulated states.
🔗 www.biorxiv.org/content/10.1...

(1/5)
Antigen-reactive CD4+ T cells after SARS-CoV-2 vaccination show divergent phenotypic states with or without restimulation bias
Understanding antigen reactivity is crucial for characterizing CD4+ T helper (Th) cell fate, yet conventional peptide restimulation assays introduce phenotypic bias by activating cells ex vivo. Howeve...
www.biorxiv.org
November 22, 2025 at 8:39 AM
Reposted by Kilian Schober
Großer Erfolg: Die @dfg.de fördert einen neuen Sonderforschungsbereich an der FAU, der Autoimmunerkrankungen untersucht. Zudem wurde für gleich zwei Transregio-Projekte mit FAU-Beteiligung eine weitere Förderperiode bewilligt. 🥳

👇 Mehr erfahren: www.fau.de/2025/11/news...
FAU mit drei Sonderforschungsbereichen erfolgreich
Die DFG fördert an der FAU einen neuen Sonderforschungsbereich. Für zwei Transregio-Projekte mit FAU-Beteiligung hat die DFG eine weitere Förderperiode bewilligt.
www.fau.de
November 21, 2025 at 2:52 PM
Reposted by Kilian Schober
Our new paper is out in Nature - online today!
Huge congrats to shared first authors Sofía Ibáñez-Molero & Johanna Veldman, the whole team & all collaborators.
📄 Open-access paper: www.nature.com/articles/s41...
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples - Nature
Tumour-reactive CD8+ T cells are enriched in functional clusters with tumour cells and/or antigen-presenting cells and can be isolated and expanded from clinical samples.
www.nature.com
November 19, 2025 at 9:00 PM
Reposted by Kilian Schober
Retrospective In Silico Analysis of Routine Laboratory Data Supports a Specific Association of Epstein–Barr Virus and Multiple Sclerosis

onlinelibrary.wiley.com/doi/10.1111/...
Retrospective In Silico Analysis of Routine Laboratory Data Supports a Specific Association of Epstein–Barr Virus and Multiple Sclerosis
To study the association of Epstein–Barr virus (EBV) and multiple sclerosis (MS) as compared to 10 different control diseases, 10,669 patients with MS and 42,222 controls were identified by ICD10 cod...
onlinelibrary.wiley.com
November 13, 2025 at 3:56 PM
Reposted by Kilian Schober
Today I appointed Jürgen Held as a Professor at FAU.

His work advances fungal diagnostics, metagenomic infection detection, and AI-based risk assessment. He brings science and clinical practice together to identify infections earlier and treat patients more precisely.
November 13, 2025 at 12:10 PM
Reposted by Kilian Schober
New Comment

Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease

www.thelancet.com/journals/lan...
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease
Long COVID is an umbrella term for the heterogeneous long-term consequences of SARS-CoV-2 infection. It encompasses a wide spectrum of phenotypes (sometimes overlapping), and its underlying mechanisms...
www.thelancet.com
November 9, 2025 at 7:52 PM
Reposted by Kilian Schober
One analytical model shows that, as of November 5th, the dismantling of U.S.A.I.D. has already caused the deaths of 600,000 people, two-thirds of them children. https://newyorkermag.visitlink.me/jUzNSc
The Shutdown of U.S.A.I.D. Has Already Killed Hundreds of Thousands
The short documentary “Rovina’s Choice” tells the story of what goes when aid goes.
newyorkermag.visitlink.me
November 6, 2025 at 9:00 PM
Epigenetically Controlled ZEB2 Expression Promotes the Cytotoxic Potential of CMV-Specific CD8+ T Cells

onlinelibrary.wiley.com/doi/10.1002/...

It was a pleasure to contribute to this work by Jochen Hühn and his team (Helmholtz Braunschweig).
Epigenetically Controlled ZEB2 Expression Promotes the Cytotoxic Potential of CMV‐Specific CD8+ T Cells
Differentially methylated regions (DMRs) within the ZEB2 locus progressively demethylate during CD4+ and CD8+ T cell differentiation into cytotoxic CD4+ and CD8+ TEMRA subsets, respectively. This epi...
onlinelibrary.wiley.com
November 6, 2025 at 2:29 PM
Reposted by Kilian Schober
#PreprintClub is now on Bluesky!

Who are we and what are we doing? We are a group of enthusiastic scientists that gather together once a week to discuss fresh preprints in the field of #immunology. 🦠🧬
December 10, 2024 at 1:51 PM
Reposted by Kilian Schober
Statistical thinking is a core part of solid biological results. However, many studies still include insufficient sample sizes, have poor experimental design, or select incorrect statistical tests.

Here, the authors present ten statistical tips for cell biology

www.nature.com/articles/s41...
Ten essential tips for robust statistics in cell biology - Nature Cell Biology
Statistical thinking is a core part of solid, trustworthy biology. However, many studies still include insufficient sample sizes, have poor experimental design or select an incorrect statistical metho...
www.nature.com
November 4, 2025 at 7:52 PM
Dear single-cell bluesky community: We’re running Cell Ranger (5’ scRNA-seq) on sorted human CD8+ T cells with a custom library. Custom seqs (27–133 bp) appear in FASTQs + BAM but aren’t mapped. They are filtered out by STAR for being too short—any way to lower the length limit or workaround?
November 3, 2025 at 10:16 AM
Reposted by Kilian Schober
I've been asked about this paper (www.nature.com/articles/s41...) enough times that I finally had to read it.

The basic claim is that mRNA vaccines had huge synergistic benefit with checkpoint blockade against lung cancer melanoma.

tl;dr it's glam-slop & everyone involved should be embarrassed
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
mRNA vaccines targeting SARS-CoV-2 also sensitize tumours to immune checkpoint inhibitors.
www.nature.com
October 30, 2025 at 3:35 PM
Reposted by Kilian Schober
Interested in joining the Powrie Lab? We’re looking for a Postdoctoral Researcher to study the neutralisation capacity of human anti-IL-10 autoantibodies. You’ll be part of our new MRC CoRE in Exposome Immunology!🧫🦠

Find out more here & apply by 11th Nov: bulletin.ndorms.ox.ac.uk/c/126QDJVBd0...
bulletin.ndorms.ox.ac.uk
October 29, 2025 at 8:55 PM
Reposted by Kilian Schober
How is the persistence of compartmentalized inflammation sustained in MS?
Our new study in
@cp-immunity.bsky.social
offers some hints.

cell.com/immunity/ful...

Thanks and congratulations to all contributors
October 29, 2025 at 3:01 PM
Reposted by Kilian Schober
🚨 The #HIRI invites applications for 2 JUNIOR GROUP LEADER POSITIONS in the areas of:

🔵 RNA Biology
🔵 RNA Medicine
🔵 RNA Technology

Apply by October 31 at www.helmholtz-hiri.de/en/jobs-tale...

Find an overview in this thread. 🧵👇

(1/6)
E15 Groups
The Helmholtz Institute for RNA-based Infection Researchopens a call for
www.helmholtz-hiri.de
October 28, 2025 at 4:04 PM
Reposted by Kilian Schober
Mapping of CD8 T-cell recognition to latent EBV infection and neuroantigens reveals HLA-specific depletion of T-cell responses in multiple sclerosis https://www.biorxiv.org/content/10.1101/2025.10.23.682742v1
October 24, 2025 at 1:15 PM
Reposted by Kilian Schober
Together with Ralf Bartenschlager @ciid-heidelberg.bsky.social we are looking for a PhD student!

The project @trr179.bsky.social will revolve around (Hepatitis) viruses and the regulation of pattern recognition receptors in innate antiviral immunity.

Contact us if you're interested!
#PhDPosition
October 23, 2025 at 2:18 PM
Reposted by Kilian Schober
📢 We are announcing the Adaptive Immune Profiling Challenge 2025!
Can you predict immune state labels from adaptive immune receptor repertoires?
💰 $10,000 prize pool!
🗓️ Launches Nov 5 on @kaggle.com
More Info: uio-bmi.github.io/adaptive_imm...
October 22, 2025 at 7:09 PM
Reposted by Kilian Schober
Also tomorrow, Cindy Xintong Li from the University of Oxford will present a preprint about how TCR activation impairs CAR-T cytotoxicity against separate target cells. @kischober.bsky.social

www.biorxiv.org/content/10.1...
October 21, 2025 at 3:52 PM
Eva Brunner joins us as a new PhD student.

Eva studied Applied Biochemistry at the Nuremberg Institute of Technology). During her master thesis, she functionally investigated eosinophils in cutaneous leishmaniasis.

(1/2)
October 21, 2025 at 11:40 AM
Reposted by Kilian Schober
LJI is recruiting!
The La Jolla Institute for Immunology (LJI, San Diego, California) invites applications for a tenure-track faculty position.
October 20, 2025 at 3:14 PM
Reposted by Kilian Schober
Happy World #CRISPR Day, everyone! ✂️🧬
October 20, 2025 at 7:58 AM
Reposted by Kilian Schober
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis: Cell www.cell.com/cell/fulltex...
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis
The first-in-human study of anti-BCMA CAR-T therapy for progressive multiple sclerosis shows a favorable safety profile, depletion of plasma cells in the central nervous system, and alleviation of mic...
www.cell.com
October 17, 2025 at 7:39 AM